/Investor DB

Borealis Ventures

Venture capital

Hanover · Pre-Seed–Series A · 13 people tracked

Also known as BOREALIS VENTURE MANAGEMENT II, LLC

Find your way into Borealis Ventures

4,841 people in our graph share verified history with the Borealis Ventures team — schools, employers, funds. One of them is your warm intro.

Micherice Taounlockedknows Peter Bertone · together at Venture Lab (overlapped)
knows the team · via Compass Therapeutics
×10knows the team · via .406 Ventures
✨ Fox Verdict
Sign up to see your fit

Investment thesis

Borealis Ventures invests in the healthcare sector, aiming to bring together the resources and expertise needed to build visionary healthcare companies. The firm's public-facing messaging centers on supporting healthcare startups, as reflected in its portfolio companies spanning biotech and therapeutics.

Source: firm website, verified Sep 29, 2026.

What founders say

No founder feedback on Borealis Ventures yet.

Stage
Pre-Seed–Series A
Check
$1M – $2.5M
HQ
Hanover, New Hampshire, US
Instruments
Equity
Founded
2002
Last 12 months
3 investments
Private fund assets
$87.4M
VC funds
5
Tracked investments
20
IPOs
1
Acquisitions
2

Team · 13 people

from the firm's website & curated & public directories
Emily Snyder· Principalin
Peter Bertone· Venture Fellowin
Dave Whitehead· Venture Consultantin

Founder mafia

5 people who came through Borealis Ventures went on to found or lead other companies.

What they invest in

from 12 of 20 portfolio companies

Healthtech ×8Biotech ×7Medical Devices ×6AI & Machine Learning ×5Digital Health ×4Construction Tech ×3SaaS ×3B2B Marketplaces ×1

HQs:United States×9Canada×1United Kingdom×1

Investments · 20 tracked

founders shown can be your intro path

By year:2026 · 22025 · 22024 · 22023 · 22021 · 12020 · 12018 · 12013 · 22012 · 12007 · 12005 · 217 dated

Compass Therapeuticscompasstherapeutics.comin𝕏NASDAQ: CMPXJun 2020 · $60M

Compass Therapeutics uses proprietary antibody discovery platforms to generate and screen diverse panels of monoclonal and multispecific antibodies, aiming to identify synergistic therapeutic combinations.

BiotechHealthtechCambridge, US

Schuetz Thomas(Executive Officer, Director)inErrik Anderson(Executive Officer, Director)inThomas J. Schuetz(Executive Officer, Director)inVered Bisker-Leib(Executive Officer)inBarry Shin(Chief Financial Officer)inNeil Lerner(Senior Vice President, Chief Accounting Officer)in

Co-investorsBioBritF-Prime CapitalForesite CapitalGV (Google Ventures)OrbiMedvenBio Partners+2 more

Ovationovation.ioinSep 2024SEC filingmedium confidence

Ovation provides access to genomic data linked to clinical information at scale to support drug discovery and precision medicine development.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesPortland, US

Winston Brasor(Co-Founder and GM LIMS)inBarry Wark(Co-Founder & Chief Strategy Officer)inBarry Wark, PhD(Co-Founder & Chief Strategy Officer)Curtis Medeiros(Executive Officer, Director)

BoardSoma Somasegar(Director)

Board seatPhil Ferneau· per SEC Form D · $10M raise · filed Sep 2024

Co-investorsMadrona Venture GroupNat TurnerSignalFire

Astra Therapeuticsastratherapeutics.com

Drug development company creating species-specific tubulin inhibitors (Parabulins) for parasitic diseases.

Co-investorsBorealis VenturesCompanion FundKickfund

Avedroavedro.comin𝕏Mar 2013 · $43Macquired by Glaukos

BiotechHealthtechMedical DevicesWaltham, US

David F. Muller(Executive Officer, Director)inBrian J. Roberts(Executive Officer)inRhonda J. Bracey(Executive Officer)in

BoardJason Hong(Director)Jeff Dykan(Director)inAnthony Natale(Director)in

Co-investorsAPERTURE Venture PartnersLAVLilly Asia VenturesSCP Vitalife PartnersThird Point VenturesFlagship Pioneering+2 more

Avitideavitide.comSeries A · Mar 2013 · $1Macquired by Repligen

Repligen provides bioprocessing technologies—including process intensification, tangential flow filtration, chromatography, process analytics, and single-use fluid management—for upstream and downstream biopharmaceutical workflows.

BiotechHardwareMedical DevicesLebanon, US

Tillman Gerngross(Director)Errik Anderson(Director)inWarren Kett(Executive Officer)Jon Sheller(Executive Officer)Kevin Issett(Executive Officer, Director)Kevin Isett(Executive Officer, Director)

Co-investorsOrbiMedSV Health InvestorsMithril Capital ManagementNeomed ManagementPolaris PartnersSands Capital Ventures+1 more

BuildFactorybuildfactory.ioPre-Seed · Nov 2025 · $5M

BuildFactory runs an AI-powered software marketplace connecting construction contractors with off-site fabrication shops to plan, route, and track prefabricated building components.

Co-investorsBuilding VenturesInnoventures IowaISA Ventures

Eaigleeaigle.cominJun 2026

Co-investorsBoreal VenturesGood News VenturesMaRS

enVistainSeries A · May 2007 · $5M

Carmel, US

Jim Barnes(Chief Executive Officer and Manager of LLC)John Stitz(Manager of LLC)Bruce Eicher(Chief Financial Officer)

FidoCurefidocure.comin𝕏Series A

One Health operates a clinical trial platform using canine cancer data to accelerate and de-risk human oncology drug development.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US

Christina Lopes(Co-Founder & CEO)inBenjamin Lewis(Co-Founder)inchristina lopes(Founder)in

Co-investorsAndreessen HorowitzaVentureCivilization Ventures Management, LlcGlobal BrainIKJ CapitalMaC Venture Capital+12 more

Kento Healthkentohealth.cominPre-Seed · Oct 2023 · $6M

Kento develops AI-powered clinical decision support models that integrate wearable sensor data, device readings, and patient-reported signals into actionable summaries for clinicians.

AI & Machine LearningDigital HealthHealthtechMedical DevicesWellness & Fitness

BoardLaura Cohen(Preventive Cardiologist)Steven Keteyian(Director, Preventive Cardiology)Francisco Lopez-Jimenez(Chair of Preventive Cardiology)Fatima Rodriguez(Section Chief, Preventive Cardiology)

Co-investorsAmplify CapitalBoreal VenturesBroom VenturesGraphite VenturesEntrepreneur FirstN49P

Newformanewforma.comin𝕏Series B · Oct 2005 · $8M

Newforma provides cloud-based information management and collaboration software for architecture, engineering, construction, and owner/operator firms throughout the project lifecycle.

Cloud ComputingConstruction TechSaaSQuebec, CA

Pete Cannone(Chief Executive Officer)in

Co-investorsEthos Private EquityBattery VenturesNorth Bridge Venture Partners & Growth Equity

Orbit Discoveryorbitdiscovery.comin𝕏Series A · May 2018 · $9M

Orbit Discovery provides peptide discovery solutions for pharmaceutical and biotechnology companies, serving both large pharmaceutical firms and smaller biotech enterprises.

AI & Machine LearningBiotechDeep TechHealthtechOxford, GB

Neil Butt(CEO)in

Co-investorsFuture Planet CapitalOxford Science EnterprisesOxford Technology ManagementPerivoli Innovations

Skillitskillit.cominSeed · Jan 2023 · $5M

Skillit provides an AI-powered hiring platform connecting construction and skilled trade recruiters with vetted craft workers across the United States.

AI & Machine LearningB2B MarketplacesConstruction TechHR TechNew York, US

FRASER PATTERSON(Executive Officer, Director)

BoardJESSE DEVITTE(Director)inRAFI SYED(Director)in

Co-investorsBow CapitalBuilding VenturesGreat North VenturesMetaPropMetaProp VenturesDPR Construction

SmartPM Technologiessmartpm.comin𝕏Series A · May 2024 · $6M

SmartPM offers a schedule analytics and project controls platform that integrates with existing CPM scheduling software to analyze construction project schedule data, flag risks, delays, and overruns.

AI & Machine LearningConstruction TechSaaSAtlanta, US

Michael Pink(Executive Officer, Director)inSean Donohue(Executive Officer, Director)Richard Pink(Executive Officer, Director)

Co-investorsBuilding VenturesGS Futures

Trivenitriveni.bioin

Triveni Bio develops genetics-informed antibody therapeutics aimed at treating complex immunology and inflammation (I&I) diseases.

BiotechDigital HealthHealthtech

Vishal Patelin

Co-investorsAscenta CapitalAtlas VentureBorealis VenturesMagnetic VenturesOrbiMedFidelity Investments+3 more

Vets First Choicevetsfirstchoice.cominJun 2012 · $4M

Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.

HealthtechMedical DevicesSaaS

Co-investorsHarbor Light Capital PartnersMountain Group CapitalClayton Dubilier & RiceHLM Venture PartnersRock Springs CapitalSequoia Heritage+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AnkyraMy FLiiPParaitoSpaceClaim

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.

Exits · 3

1 IPOs · 2 acquisitions

Compass TherapeuticsNASDAQ: CMPXAvedroacq. by GlaukosAvitideacq. by Repligen

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Borealis Ventures made?
Borealis Ventures has 20 tracked investments, 3 of which have exited, including 4 dated in the last 24 months.
What stage does Borealis Ventures invest at?
Borealis Ventures invests at the Pre-Seed, Seed, Series A stages.
What is Borealis Ventures's typical check size?
Borealis Ventures typically writes checks of $1M – $2.5M.
What sectors does Borealis Ventures focus on?
Borealis Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Borealis Ventures located?
Borealis Ventures is headquartered in Hanover, US.
Who does Borealis Ventures co-invest with?
Borealis Ventures most often shares deals with Borealis Ventures, Ascenta Capital, Atlas Venture, among 7 tracked co-investors.

Media · Podcasts & interviews

featuring the team

Eyes on Animal Health | Julia Stephanus (Borealis Ventures)

AgriNovus Indiana · Julia Stephanus

Co-investors · 8

OrbiMed

OrbiMed is a healthcare-focused investment firm providing tailored financing solutions and global resources to build world-class healthcare companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

$1M – $75M
Polaris Partners

Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.

Both backed · 3
$500K – $5M
Atlas Venture

Atlas Venture is a life sciences venture capital firm with three decades of experience investing in and building biotech and medical innovation companies, including startups launched from its own incubator.

Both backed · 1
$500K – $1M
Mithril Capital Management

Mithril Capital Management is a multi-billion-dollar investment firm launched in 2012 with a 'Building to Last' mission, backing technology teams building durable businesses in industries overdue for change. Its committed funds are anchored by investor Peter Thiel.

Both backed · 1
Flagship Pioneering

Flagship Pioneering is a firm that creates and builds companies to pioneer breakthroughs in science and technology for people and the planet, active for over 25 years.

Both backed · 1
$500K – $10M
SV Health Investors

SV Health Investors is a global private equity and venture capital platform dedicated to healthcare, running specialized funds across biotechnology (including dementia), healthcare growth equity, and medtech.

Both backed · 1
$1M – $20M
Oxford Science Enterprises

Oxford Science Enterprises builds and funds companies founded on science and research from the University of Oxford, targeting deep tech, life sciences and healthtech.

Both backed · 1
$63.5K – $31.8M
Founders Fund

Founders Fund is a venture capital firm that backs technology companies building transformative products.

$500K – $5M

Firms observed investing alongside Borealis Ventures, from public investor directories. Shared companies are the overlap with Borealis Ventures's recorded portfolio.

Similar investors

Featured in lists